Latest filing published 21 Oct 2016 for BIOCEPT INC, €228k.
Insider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Claire Reiss: trading record in brief
Claire Reiss discloses dealings in Biocept Inc to SEC (Form 4). In total, 5 filings cover trades dated from 10 February 2014 to 19 October 2016.
No open-market sale appears; the market trades are 2 purchases worth €762k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Since January 2016: 2 purchases and no sales on the market.
The record was last updated on 21 October 2016 with an open-market purchase (€228k) in Biocept Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Claire Reiss
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 227,272 shares@ US$1.1029.9% of flowCommon StockSEC:0001209191-16-146633:0Canonical exit: 17 Jan 2017 (T+90)
- 614,273 shares@ US$1.0070.1% of flowCommon StockSEC:0001209191-16-117954:0Canonical exit: 2 Aug 2016 (T+90)
- 420,430 shares@ US$10.00Common StockSEC:0001209191-14-017631:0
- 257,031 shares@ US$10.00Common StockSEC:0001209191-14-009974:0
- 13,453 shares@ US$10.00Common StockSEC:0001209191-14-009974:1
5 of 5 declarations